Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Summary not available.
Henry Schein (NASDAQ: HSIC) has donated over $100,000 to TeamSmile, a non-profit providing dental care to underserved children. This year alone, the company contributed $30,000 in cash, nearly $40,000 in dental supplies, and $25,000 for practice management software training. Since 2007, donations have reached approximately $1 million. TeamSmile has served over 40,000 children, offering over $17 million in free dental care. The remaining TeamSmile event for 2021 will be held at Mercedes-Benz Stadium in Atlanta, GA.
Henry Schein has appointed Scott Serota, former President and CEO of Blue Cross Blue Shield Association, to its Board of Directors effective immediately. Serota, who expanded BCBSA's membership from 65 million to over 100 million, is expected to contribute his healthcare expertise to advance the company's strategic goals. Meanwhile, Barry Alperin will retire from the Board in May, adhering to the director resignation policy upon reaching 80 years of age. This change aims to bolster leadership and a focus on public health challenges.
Henry Schein Orthodontics has launched Studio Pro™ 4.0, an advanced web-based treatment planning software for Reveal® Clear Aligners. This new platform, integrated with the DDX® Case Management Portal, enables providers to customize treatment plans with over 25 new features, enhancing user experience for practitioners of all skill levels. Phil Prentice, President of Henry Schein’s Orthodontics Group, emphasized the software's role in simplifying workflows. The software aims to improve patient communication and treatment control, marking a significant advancement in orthodontic technology.
Henry Schein, Inc. (NASDAQ: HSIC) showcases its innovative products and solutions at the 2021 Greater New York Dental Meeting, aiming to improve practice efficiency for oral health professionals. Attendees can explore product demonstrations from leading brands and a new loyalty program, Henry Schein Thrive Rewards. Educational courses, including one on Revenue Cycle Management, are also featured. Notable solutions include practice management software, patient communication tools, and advanced dental technology, enhancing patient experiences and practice workflows.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in three virtual investor conferences in December 2021. The events include the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1, Nasdaq's 44th Virtual Investor Conference at 11:30 a.m. ET on December 2, and the Evercore ISI 4th Annual HealthCONx Virtual Conference at 1:00 p.m. ET on the same day. Live webcasts of the two latter presentations will be accessible to registered attendees.
Henry Schein Cares Foundation, in collaboration with the UPS Foundation, announced the third phase of the "Wearing is Caring" campaign aimed at promoting health equity and access to COVID-19 vaccines. Launched in October 2020, the initiative addresses healthcare disparities in underserved communities. A CDC report indicates that only 56% of Americans are fully vaccinated, with lower rates among minority groups. The campaign emphasizes the role of primary care physicians in vaccination decisions, with 88% of survey respondents citing their doctor’s advice as influential.
Zimbis has launched a partnership with Southern Anesthesia & Surgical (SAS) to enhance medication and supply management for dental professionals. This collaboration introduces an order integration system that streamlines inventory management, allowing automatic population of product reorder information on SAS's website. By improving operational efficiencies, this partnership aims to enable dental surgeons to focus more on patient care. Both companies anticipate that this integration will significantly benefit the dental surgery market.
Henry Schein reported record third-quarter net sales of $3.2 billion, marking an 11.9% increase year-over-year. GAAP diluted EPS rose to $1.15 from $0.99, while non-GAAP diluted EPS reached $1.10, up from $1.03. The company raised its 2021 non-GAAP diluted EPS guidance to between $4.27 and $4.35, reflecting a growth of 44% to 46% compared to 2020. Preliminary guidance for 2022 indicates mid to high single-digit growth over the 2021 guidance. Strong sales growth was seen across Global Dental and Medical segments.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, has committed to a long-term goal of net-zero emissions by 2050. The company has signed the Business Ambition for 1.5⁰C initiative, aiming to set science-based emissions reduction targets. This move is part of a broader strategy to address climate change and improve sustainability within the health care supply chain. Henry Schein will focus on establishing emissions metrics across key markets in North America, Europe, and Australia.